EXCERPT FROM AN ARTICLE IN FORBES 2020 MAGAZINE:

Optopol Technology was founded in January in 1992 by the late Adam Bogdani, whose son Marcin still runs the company today. His main goal was to build a Polish company with local capital and to bring modern and professional diagnostic equipment to the world. Optopol Technology was successful in their release of automated perimeters and Optical Coherence Tomography (OCT) and in 2010, the company was acquired by the Japanese company Canon. The family re-acquired Optopol Technology in 2014 and Marcin Bogdani took over as the President. The company began its rebirth by distributing other ophthalmic equipment from leading manufacturers in the industry, while beginning production of a more modern version of their original devices.  

The turning point for the company from Zawiercie, Poland was the start of production of the world’s first spectral domain OCT developed for commercial use. Spectral domain optical coherence tomographs greatly improved the quality of retinal images and allowed eye care professionals to see pathology more clearly and begin earlier treatment. The spectacular success of the optical tomograph was possible thanks to the cooperation of Optopol with scientists from the Institute of Medical Physics of the Nicolaus Copernicus University in Toruń, Poland and brought international recognition to the company.

Many ophthalmic equipment manufacturers, including Canon, became interested in Optopol. Following the acquisition, cooperation with Japanese engineers contributed to improving the quality of the devices and expanding knowledge in the field of constructing and building optical systems at the highest level. After returning to the Bogdani family in 2014, the company has had many successes. New devices have been developed including the “REVO NX 130”,  the first commercial OCT with a speed exceeding 130,000 A-scans per second and currently the world’s fastest commercial ophthalmic OCT technology. 

At the same time as the REVO series OCT product line, the company started production of new automated perimeters. In 2016 the PTS-925W perimeter and in 2017 the model PTS-2000. These perimeters have maintained an excellent reputation around the world and are currently being used by over 6,000 eye care professionals. In 2019, the company proudly presented its latest multifunction OCT, the REVO FC, combining the full functionality of an optical tomograph and a fundus camera. The REVO FC is the first device that is a combination of Spectral Domain OCT, Fundus Camera and optical biometer, enabling imaging of several eye structures using one unit. 

An important area for an enterprise is the distribution of its goods. Although Europe remains the main distribution center, Africa, Asia, North and South America and Australia are also playing an increasingly important role. Optopol Technology focuses on continuous development, which results in a constantly growing number of distributors around the world, which currently covers as many as 90 countries. One major contribution to the company’s success is due to the successful placement of  perimeters in the North America, where at the beginning of 2020 it was decided to open a direct subsidiaray called “Optopol USA”  and start the process of gaining approval from the American Food and Drug Administration (FDA) for the REVO NX130 OCT device. 

Many years of experience, a clear vision of development, excellent quality of manufactured devices, professional staff as well as global trade experience and comprehensive after-sales service are the elements most valued by customers around the world. Optopol continues to create new devices that will help ophthalmologists and optometrists around the world to provide better vision for their patients.